FDA updated Safety Communication: Ondansetron (Zofran) 32-mg, single IV dose pulled due to potential for serious cardiac risks

Patients who used the Bigfoot Unity Diabetes Management System had glycemic control and reduced diabetes distress.

This episode explores how pharmacists can navigate their careers with clarity and purpose by grounding themselves in their professional oath, organizational mission, and core values.

As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.

With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.